LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Navaratnam, K; Alfirevic, A; Alfirevic, Z (2016)
Publisher: John Wiley and Sons Inc.
Journal: Bjog
Languages: English
Types: Article
Subjects: Review Article, pre?eclampsia, pregnancy, aspirin, platelet, Activation, resistance
Antiplatelet agents are pivotal for prevention of coronary artery disease and cerebrovascular disease worldwide. Individual patient data meta?analysis indicates that low?dose aspirin causes a 10% risk reduction in pre?eclampsia for women at high individual risk. However, in the last 15 years it has emerged that a significant proportion of aspirin?treated individuals exhibit suboptimal platelet response, determined biochemically and clinically, termed ?aspirin non?responsiveness?, ?aspirin resistance? and ?aspirin treatment failure?. More recently, investigation of aspirin responsiveness has begun in pregnant women. This review explores the history and clinical relevance of ?aspirin resistance? applied to high?risk obstetric populations. Tweetable abstract Is ?aspirin resistance? clinically relevant in high?risk obstetrics?

Share - Bookmark

Cite this article

Collected from